MedTrace Logo

Nutritional Impact of a Project on Food Security and Nutrition in Children Receiving Micronutrient Powders in Colombia

NCT03313089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2018-10-15

No results posted yet for this study

Summary

The effectiveness of micronutrient powders or MNP as a strategy for the prevention of micronutrient deficiencies has been described in the literature. However, few studies have shown the impact of the inclusion of other simultaneous actions on the different dimensions of food and nutritional security (as in the case of the project "Papas más nutritivas") that will contribute to the improvement of nutritional status, obtaining potentially greater benefits.

The objective is to establish the existence of difference in hemoglobin values (and other biochemical parameters as secondary outcomes) among children aged 6 months to 5 years who receive home fortification with micronutrient powders (MNP) belonging to the project "Papas más nutritivas", and children with home fortification with MNP but not belonging to the project.

Conditions

Interventions

BEHAVIORAL

"Papas más nutritivas" (PSAN)

Activities of the project "Papas más nutritivas"

Sponsors & Collaborators

  • International Development Research Centre, Canada

    collaborator OTHER_GOV

  • McGill University

    collaborator OTHER

  • Universidad Nacional de Colombia

    lead OTHER

Principal Investigators

  • Sara E. Del Castillo Matamoros, Professor · Universidad Nacional de Colombia

  • Javier H. Eslava Schmalbach, Professor · Universidad Nacional de Colombia

  • Nathalie Ospina Lizarazo, Student · Universidad Nacional de Colombia

Eligibility

Min Age
6 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-07
Primary Completion
2017-11-26
Completion
2017-11-26

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03313089 on ClinicalTrials.gov